Adagio Medical Holdings, Inc Common Stock
ADGM Real Time Price USDRecent trades of ADGM by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ADGM's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Flow manifold for cryoablation catheter Dec. 10, 2024
-
Patent Title: Endovascular near critical fluid based cryoablation catheter and related methods Jan. 30, 2024
-
Patent Title: Cryoablation element with conductive liner Sep. 12, 2023
-
Patent Title: Ablation catheter having a shape memory stylet Jan. 31, 2023
-
Patent Title: Cryotherapy probe Dec. 14, 2021
-
Patent Title: Endovascular near critical fluid based cryoablation catheter and related methods Nov. 23, 2021
-
Patent Title: Tissue contact verification system Jul. 06, 2021
-
Patent Title: Endoesophageal balloon catheter, system, and related method Mar. 23, 2021
-
Patent Title: Ablation method for creating elongate continuous lesions enclosing multiple vessel entries Dec. 15, 2020
-
Patent Title: Endovascular near critical fluid based cryoablation catheter and related methods Jun. 02, 2020
-
Patent Title: Pressure modulated cryoablation system and related methods Jan. 28, 2020
-
Patent Title: Cryotherapy probe Dec. 25, 2018
-
Patent Title: Cryotherapy probe Aug. 09, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ADGM in WallStreetBets Daily Discussion
Recent insights relating to ADGM
Recent picks made for ADGM stock on CNBC
ETFs with the largest estimated holdings in ADGM
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ADGM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.